Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations

Affiliated Hospital of Nantong University300 enrolled

Overview

The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke

A randomized controlled study was conducted on the application of smart wearable devices in the intervention of high-risk populations for stroke, with a focus on whether the functions of smart wearable devices such as medication reminders, heart rate monitoring, and exercise reminders can effectively benefit the improvement of key risk factors for stroke, especially blood pressure, blood glucose, and blood lipids.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

300

Conditions

Hypertension Diabetes Atrial Fibrillation Dyslipidemia Smoking Physical Inactivity Obesity and Overweight

Interventions

Wearable DevicesBEHAVIORAL

Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.

Eligibility

Sex: ALLMin age: 30 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Diagnosed with hypertension; 2. Diagnosed with diabetes; 3. Diagnosed with atrial fibrillation; 4. Smoking subjects; 5. Physical inactive subjects； 6. Obesity and overweight subjects; 7. Must be able to use smart wearable devices. Exclusion Criteria: 1. Diagnosed with malignancies; 2. Diagnosed with psychiatric disorders; 3. Diagnosed with cognitive impairment; 4. Unable to operate smart wearable devices.

Locations (1)

Affiliated Hospital of Nantong University

Nantong, Jiangsu, China

RECRUITING

Outcomes

Primary Outcomes

medication adherence and risk factor control rates

1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.

Time frame: 6 months

Secondary Outcomes

incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events

Stroke is a sudden interruption of blood flow to the brain, caused by either a blockage (ischemic stroke) or rupture of a blood vessel (hemorrhagic stroke). Coronary heart disease is a cardiovascular condition characterized by the narrowing or blockage of the coronary arteries, the blood vessels that supply oxygen-rich blood to the heart muscle. Peripheral vascular diseases are circulatory disorders characterized by narrowing, blockage, or spasms in blood vessels outside the heart and brain, most commonly affecting arteries supplying the legs, arms, kidneys, or stomach.

Time frame: 6 months

Central Contacts

Qiuhong Ji, MD, PhD

CONTACT

+8613962916293 jiqiuhong@ntu.edu.cn

Pengyu Gong, MD

CONTACT

+8615720800870 gongpengyu@ntu.edu.cn

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.